Mobileum and Telkomsel Partner to Deliver Scalable, AI-Powered Insights for Indonesian Enterprises
10.9.2025 10:00:00 EEST | Business Wire | Press release
Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, and PT Telekomunikasi Selular (“Telkomsel”), the leading digital telecommunication service provider in Indonesia and Southeast Asia region, today announced a strategic partnership to deliver high-impact, AI data-driven solutions that help Indonesian enterprises unlock growth, drive innovation, and improve operational efficiency.
The partnership combines Mobileum’s expertise in transforming massive, complex telco data insights, into real-time, multi-dimensional AI insights with Telkomsel’s leadership in driving Indonesia’s digital transformation. By leveraging Telkomsel’s customer-centric B2C services and innovative B2B offerings, including IoT and Big Data, the collaboration empowers cross-sector innovation. Together, the companies will equip enterprises, including SuperApp providers and digital service platforms, with the intelligence to personalize experiences, optimize engagement, and scale effectively in a dynamic market.
Creating value for Indonesian enterprises
Enterprise customers will gain access to real-time market intelligence, behavioral analytics, and flexible commercial models – delivered through responsible, insight-driven solutions that support strategic decision-making and align with evolving data governance standards.
Initial focus areas include:
- Market share insights for ride-hailing, food delivery, EV, and mobile banking apps
- Behavioral analytics across video, ecommerce, travel, health, and education platforms
- Smart home and broadband user profiling for next-generation digital services
“Today’s enterprises, especially digital-first players like SuperApp providers, need real-time, multi-dimensional insights to stay ahead,” said Raja Hussain, Chief Revenue Officer of Mobileum. “Through this partnership, Telkomsel leverages Mobileum’s AI-powered analytics engine to process telco data insights within a controlled and secure environment, ensuring full compliance with local data sovereignty principles that helps businesses improve engagement, benchmark performance, and deliver more personalized experiences.”
“At Telkomsel, we are committed to accelerating Indonesia’s digital ecosystem by equipping businesses with the innovative and impactful solutions they need to thrive,” said Telkomsel’s Vice President Data Solutions and Digital Financial Services, Alfian Manullang. “This partnership enhances our ability to provide timely, AI data-driven insights that help enterprises innovate faster, operate more efficiently, and uncover new opportunities for sustainable growth. By combining our leadership in building an inclusive, competitive digital society with Mobileum’s advanced analytics capabilities, we’re delivering measurable value that empowers businesses today while helping shape a brighter digital future for Indonesia.”
Powered by Mobileum’s DNA platform
The collaboration is built on Mobileum’s Deep Network Analytics (DNA) platform, which uses machine learning and geo-analytics models to unlock the hidden value of operator’s network data. Designed to inform strategic decision-making, DNA delivers granular, real-time insights into customer behavior, market trends, and application engagement. Mobileum DNA enables enterprises to launch targeted campaigns, identify new revenue opportunities, and establish digital partnerships – all while upholding data privacy standards and maximizing marketing return on investment.
About Mobileum Inc.
Mobileum is a leading provider of Telecom analytics solutions for roaming, core network, security, risk management, domestic and international connectivity testing, and customer intelligence. More than 1,000 customers rely on its Active Intelligence platform, which provides advanced analytics solutions, allowing customers to connect deep network and operational intelligence with real-time actions that increase revenue, improve customer experience, and reduce costs. Headquartered in Silicon Valley, Mobileum has global offices in Australia, Germany, Greece, India, Japan, Portugal, Singapore, UK, and United Arab Emirates.
Learn more in https://www.mobileum.com/.
About Telkomsel
Telkomsel is the region’s leading digital telecommunications service provider, committed to empowering Indonesian society to be highly competitive and creating a bright future by providing connectivity, innovative and superior services, and solutions for everyone, every home, and every business, thus opening up all possibilities. Aligned with the spirit of digitizing Indonesia, Telkomsel acts as the largest convergence service provider, consistently expanding its 4G network that now covers 97% of the population. As the pioneer of 5G commercialization in Indonesia, Telkomsel affirms its position as the leading and most expansive 5G operator with more than 3,000 5G BTS units. Telkomsel also implements the latest technology, utilizing end-to-end implementation of Artificial Intelligence (AI)-powered Autonomous Network, to enhance service quality and customer experience, while continuing to develop digital services such as Digital Lifestyle, Digital Advertising, Digital Enterprise Solutions, and the Internet of Things. Throughout its 30 years of history, Telkomsel now operates more than 280,434 BTS, serving over 158.4 million mobile customers, and more than 10 million fixed broadband (IndiHome) customers nationwide. In its commitment to sustainable operations, Telkomsel adheres to ESG principles to create a positive impact on its ecosystem. For more detailed information and customer services, please visit www.telkomsel.com, follow us on Facebook at facebook.com/Telkomsel, Twitter ”X” @telkomsel, and Instagram @telkomsel, or connect with our virtual assistant through the MyTelkomsel app.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250910376923/en/
Contacts
Useful Contacts:
QUEXOR GROUP INC.
Cheryl Fritz | cfritz@quexor.com | Mob.: +1 (703) 856-5932
Media and Corporate Communications – Mobileum
Sandra Almeida | sandra.almeida@mobileum.com | Mob. +351 939650229
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom